United Therapeutics (UTHR) Posts Q1 EPS of $1.24
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $1.24, which may not compare to the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
